Literature DB >> 11356613

Shear stress-induced vasodilation in porcine coronary conduit arteries is independent of nitric oxide release.

S Dube1, J M Canty.   

Abstract

The present study was performed to determine the importance of nitric oxide in eliciting epicardial coronary artery dilation during sustained increases in shear stress in the absence of pulsatile flow. Isolated first-order porcine epicardial coronary conduit arteries (approximately 500 microm) were preconstricted (U-46619) and subjected to steady-state changes in flow in vitro. Nonpulsatile flow (shear stress range from 0 to approximately 100 dyn/cm2) produced a graded dilation of epicardial arteries. Inhibiting nitric oxide synthase with 10(-5) M N(omega)-nitro-L-arginine methyl ester (L-NAME) blocked bradykinin-induced vasodilation but did not affect the flow-diameter relation or the maximum change in diameter from static conditions (67 +/- 10 microm in control vs. 71 +/- 8 microm after L-NAME, P = not significant). The addition of indomethacin (10(-5) M) had no effect on flow-mediated vasodilation. Depolarizing vascular smooth muscle with KCl (60 mM) or removing the endothelium blocked bradykinin vasodilation and completely abolished flow-mediated responses. The K+ channel blocker tetraethylammonium chloride (TEA; 10(-4)M) attenuated flow-mediated vasodilation (maximum diameter change was 110 +/- 18 microm under control conditions vs. 58 +/- 10 microm after TEA, P < 0.001). These data indicate that epicardial coronary arteries dilate to steady-state changes in nonpulsatile flow via a mechanism that is independent of nitric oxide production. The ability to completely block this with KCl and attenuate it with TEA supports the hypothesis that epicardial coronary arteries dilate to steady levels of shear stress through hyperpolarization of vascular smooth muscle. This may be secondary to the release of an endothelium-dependent hyperpolarizing factor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356613     DOI: 10.1152/ajpheart.2001.280.6.H2581

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Dominance of flow-mediated constriction over flow-mediated dilatation in the rat carotid artery.

Authors:  John Craig; William Martin
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

2.  Ceramide signaling in the coronary microcirculation: a double-edged sword?

Authors:  Brian R Weil; John M Canty
Journal:  Circ Res       Date:  2014-08-15       Impact factor: 17.367

3.  Differential effects of ascorbate on endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation in the bovine ciliary vascular bed and coronary artery.

Authors:  Alister J McNeish; Silvia Nelli; William S Wilson; Fiona J Dowell; William Martin
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 4.  Regulation of coronary blood flow in health and ischemic heart disease.

Authors:  Dirk J Duncker; Akos Koller; Daphne Merkus; John M Canty
Journal:  Prog Cardiovasc Dis       Date:  2014-12-02       Impact factor: 8.194

5.  Different modulation by Ca2+-activated K+ channel blockers and herbimycin of acetylcholine- and flow-evoked vasodilatation in rat mesenteric small arteries.

Authors:  Michael Thorsgaard; Vanesa Lopez; Niels H Buus; Ulf Simonsen
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 6.  Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?

Authors:  Tudor M Griffith
Journal:  Br J Pharmacol       Date:  2004-03       Impact factor: 8.739

7.  LXN deficiency regulates cytoskeleton remodelling by promoting proteolytic cleavage of Filamin A in vascular endothelial cells.

Authors:  Guozhang He; Shuang Kan; Shaohua Xu; Xuchen Sun; Rong Li; Wei Shu; Ming Chen
Journal:  J Cell Mol Med       Date:  2021-06-03       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.